Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2025
FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease
29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...
Posted by Michael Wonder on 02 May 2022
Junshi Biosciences and Coherus receive complete response letter from U.S. FDA for toripalimab BLA
2 May 2022 - The complete response letter requests a quality process change Junshi Biosciences and Coherus believe is readily addressable. ...
Posted by Michael Wonder on 02 May 2022
Axsome Therapeutics receives FDA complete response letter for new drug application for AXS-07 for the acute treatment of migraine
2 May 2022 - No clinical efficacy or safety issues raised and no additional clinical studies required by FDA to support ...
Posted by Michael Wonder on 02 May 2022
Would drug makers lower their insulin prices if Congress asks nicely?
29 April 2022 - After a year's long, drawn-out debate over how to best lower patients’ prescription drug prices, two senators ...
Posted by Michael Wonder on 02 May 2022
U.S. FDA declines to approve two more China tested drugs
2 May 2022 - The U.S. FDA declined to approve two China tested cancer treatments on Monday, raising concerns over ...
Posted by Michael Wonder on 02 May 2022
Mum and son hold their breath for cystic fibrosis drug Trikafta ahead of Budget
29 April 2022 - Hamish Mountfort is a smart, well-spoken and confident 22-year-old who’s dying, literally, to dedicate his life ...
Posted by Michael Wonder on 01 May 2022
Cost of some life-saving drugs to be slashed
1 May 2022 - Changes to the PBS could save some Australians as much as $2.5 million per treatment, as others ...
Posted by Michael Wonder on 01 May 2022
More senior Australians to get cheaper health care and medication under $70m Coalition election pitch
2 May 2022 - More self-funded retirees would be able to access cheaper health care and medication under a multi-million-dollar ...
Posted by Michael Wonder on 01 May 2022
COVID-19 oral treatment listed on PBS from 1 May 2022
1 May 2022 - This prescription only oral treatment has been found to be effective in treating mild to moderate ...
Posted by Michael Wonder on 01 May 2022
Schedule of Pharmaceutical Benefits - 1 May 2022
1 May 2022 - The May 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 01 May 2022
New Pharmaceutical Benefits Scheme listings to save patients millions
1 May 2022 - Health Minister Greg Hunt has announced a series of new Pharmaceutical Benefits Scheme listings which will save ...
Posted by Michael Wonder on 01 May 2022
Moderna submits COVID-19 vaccine for kids 5 and under to Health Canada for review
29 April 2022 - Moderna has asked Health Canada to approve its COVID-19 vaccine for children as young as six ...
Posted by Michael Wonder on 01 May 2022
New Zealand Pharmaceutical Schedule - 1 May 2022
1 May 2022 - The May 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 01 May 2022
Moderna files to expand conditional marketing authorisation for its COVID-19 vaccine to include children six months to under six years in the European Union
29 April 2022 - The filing follows the European Medicines Agency's Committee for Medicinal Products for Human Use recent decision ...
Posted by Michael Wonder on 30 Apr 2022
Supernus announces FDA approval of Qelbree for the treatment of attention deficit hyperactivity disorder in adults
29 April 2022 - First novel, non-stimulant option for adults with ADHD in 20 years. ...
Posted by Michael Wonder on 30 Apr 2022
Scott Morrison pledges to cut $10 from Pharmaceutical Benefit Scheme scripts
30 April 2022 - A re-elected Morrison government would cut the price of medicines listed on the Pharmaceutical Benefit Scheme ...